Korro Bio, Inc. (KRRO)
Pharmaceutical Preparations
Latest Price
$14.07
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
5.86
P/B Ratio
2.40
Institutional Ownership
91.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 1.54M | $20.0M | 10.46% | -- | 2026-06-30 |
| NEA Management Company, LLC | 1.30M | $17.0M | 8.83% | -- | 2026-06-30 |
| Venrock Adviser, LLC | 1.01M | $13.0M | 6.86% | -- | 2026-06-30 |
| Atlas Venture Life Science Advisors, LLC | 962.9K | $12.0M | 6.55% | -174.3K | 2026-06-30 |
| Balyasny Asset Management L.P. | 951.8K | $12.0M | 6.47% | -88.3K | 2026-06-30 |
| BlackRock, Inc. | 817.6K | $10.0M | 5.56% | +357.6K | 2026-06-30 |
| Nantahala Capital Management, LLC | 660.0K | $8.0M | 4.49% | -- | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 541.0K | $7.0M | 3.68% | +312.6K | 2026-06-30 |
| ADAR1 Capital Management, LLC | 540.1K | $7.0M | 3.67% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 454.8K | $5.0M | 3.09% | +143.9K | 2026-06-30 |